In this episode, I’ll discuss using Anti-Xa vs. aPTT for heparin infusion monitoring. Subscribe on iTunes, Android, or Stitcher Over the past several years, many institutions have switched to monitoring heparin infusions with anti-factor Xa levels instead of activated partial thromboplastin time. Guidelines Expert guidelines don’t seem to take a stand either way when it […]
Episode 126: Anti-xa vs aPTT for heparin infusion monitoring
Episode 125: Adjusted weight dosing of heparin in obese patients, how long is glucose needed after high dose insulin therapy is stopped, and a resource for studying intensive care topics
In this episode I’ll: 1. Discuss an article about using adjusted body weight for heparin dosing in obese patients. 2. Answer the drug information question “How long is glucose therapy required after using high-dose insulin for beta-blocker or calcium channel blocker overdose?” 3. Share a resource for studying intensive care topics. Subscribe on iTunes, Android, […]
Joe’s Top 7 Articles from the Week of September 26th [Literature Digest]
Episode 124: Causes of fever in critically ill patients
In this episode I’ll discuss causes of fever in critically ill patients. Subscribe on iTunes, Android, or Stitcher Elevated body temperature is detected in almost half of patients admitted to adult ICUs. Its presence should trigger a thorough search for the etiology. IDSA / SCCM guidelines define pyrexia in critically ill adults as a temperature […]
Episode 123: Impact of reported penicillin allergy, nafcillin and hyperbilirubinemia, and a resource for creating images for use in your ICU education materials
In this episode I’ll: 1. Discuss an article about the impact of reported penicillin allergies. 2. Answer the drug information question “Can nafcillin cause hyperbilirubinemia?” 3. Share a resource for creating images for use in ICU education materials, protocols, and presentations. Before we begin, I’d like to share a pearl from my book, A Pharmacist’s Guide […]
Joe’s Top 7 Articles from the Week of September 19th [Literature Digest]
Episode 122: Using analgosedation in critically ill patients
In this episode, I’ll discuss using analgosedation in critically ill patients. Subscribe on iTunes, Android, or Stitcher Before we begin, I’d like to share a pearl from my book, A Pharmacist’s Guide to Inpatient Medical Emergencies: “Typical features of shock: AMS, high HR, low BP, oliguria, cool & clammy skin, acidosis” #pharmacists https://t.co/w0tP1mmQW7 — Pharmacy Joe […]
Episode 121: Andexanet alfa for reversal of rivaroxaban and apixaban, cryptococcal meningitis treatment, and PharmERToxGuy’s resources
In this episode I’ll: 1. Discuss an article about the factor Xa reversal agent andexanet alfa. 2. Answer the drug information question “What is the treatment for cryptococcal meningitis in a non-HIV infected, non-transplant patient?” 3. Share a resource for lectures and handouts by a board certified toxicologist. Show notes at pharmacyjoe.com/episode121. Before we begin, […]
Joe’s Top 7 Articles from the Week of September 12th [Literature Digest]
Episode 120: Should critically ill patients with Legionella pneumonia receive double antibiotic coverage?
In this episode, I’ll discuss whether critically ill patients with Legionella pneumonia should receive double antibiotic coverage. Before we begin, I’d like to share a pearl from my book, A Pharmacist’s Guide to Inpatient Medical Emergencies: “Causes of low O2 sat: PE, shunting, airway obstruction (functional or mechanical)” #pharmacists https://t.co/w0tP1mmQW7 — Pharmacy Joe (@PharmacyJoe) September 11, […]
Episode 119: Antibiotic exposure and infection with resistant organisms, repeat PCC dosing in rivaroxaban bleed patients, and an evidence-based healthcare resource
In this episode I’ll: 1. Discuss an article about the effects of antibiotic exposure and infection with resistant organisms. 2. Answer the drug information question “Should a second dose of 4-factor PCC be given to a patient who has refractory bleeding from rivaroxaban?” 3. Share a resource for evidence-based healthcare. Before we begin, I’d like […]
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 94
- Next Page »




